ifenprodil has been researched along with Allergic Encephalomyelitis in 2 studies
ifenprodil: NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habbas, S | 1 |
| Santello, M | 1 |
| Becker, D | 1 |
| Stubbe, H | 1 |
| Zappia, G | 1 |
| Liaudet, N | 1 |
| Klaus, FR | 1 |
| Kollias, G | 1 |
| Fontana, A | 1 |
| Pryce, CR | 1 |
| Suter, T | 1 |
| Volterra, A | 1 |
| Paul, C | 1 |
| Scott, GS | 1 |
| Barbour, MJ | 1 |
| Seiler, N | 1 |
| Bolton, C | 1 |
2 other studies available for ifenprodil and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling.
Topics: Animals; Astrocytes; Dentate Gyrus; Encephalomyelitis, Autoimmune, Experimental; Humans; Learning; M | 2015 |
N-methyl-D-aspartate receptor-mediated events contribute to neurovascular breakdown during experimental allergic encephalomyelitis.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cerebellum; Dizocilpine Maleate; Encephalomyel | 1997 |